Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.
about
Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finPlasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitorA chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formationPurification of storage granule protein-23. A novel protein identified by phage display technology and interaction with type I plasminogen activator inhibitorPlatelets retain high levels of active plasminogen activator inhibitor 1A new intracellular serine protease inhibitor expressed in the rat pituitary gland complexes with granzyme B.Grey platelet syndrome: evidence for alpha-granule localization of the platelet plasminogen activator inhibitor-1 pool.Novel risk factors of cardiovascular disease and their associations between obesity, physical activity and physical fitnessNocturnal light exposure alters hepatic Pai-1 expression by stimulating the adrenal pathway in C3H mice.Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cellscDNA cloning of human plasminogen activator-inhibitor from endothelial cellsPlasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.Chemical Antagonists of Plasminogen Activator Inhibitor-1: Mechanisms of Action and Therapeutic Potential in Vascular Disease.The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cellsThe effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assaysInterleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitorPlasminogen activator-specific inhibitors produced by human monocytes/macrophages.Regulation of plasminogen activator production by endothelial cells: role in fibrinolysis and local proteolysis.Circadian variation in fibrinolytic activity in patients with variant angina.Effect of polymyxin B and colimycin on induction of plasminogen antiactivator by lipopolysaccharide in human endothelial cell culture.The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically relatedScale up and pharmacokinetic study of a novel mutated chimeric tissue plasminogen activator (mt-PA) in rats.Platelets and fibrinolysis.The plasmin-antiplasmin system: structural and functional aspects.Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular DiseaseBiophysical Mechanisms Mediating Fibrin Fiber Lysis.Taking the stock of granule cargo: Platelet releasate proteomics.Distribution of plasminogen activator inhibitor (PAI-1) in tissues.Platelet release protein which inhibits plasminogen activatorsResolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1.Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor.Analysis of PAI-1 gene expression in vivo using in situ hybridization.Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.Importance of viability and attachment to an ascites tumor in the release of plasminogen activatorSodium nitroprusside modulates the fibrinolytic system in the rabbitRapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells.Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets.
P2860
Q24300911-48C25E0B-1035-428F-A5A4-6615807A363BQ24309484-1CD7EAB6-FDFE-49FA-A684-E0C2E24284FCQ24655336-F49E5588-50F1-4E2E-B391-0D4DD44CAB18Q27331904-7621F89D-30DE-498A-B6D9-9B2230356029Q28584987-B634F109-4D1E-4AFB-A1FC-37EDB4604743Q28743269-25E77C7A-C545-4050-BF33-FBE1735E1FACQ31942742-47B76C00-9BD4-4FF1-A75D-1E6B2FB034EBQ33373454-783772EB-431F-452A-91B7-D1AD32894D1DQ34074016-C06EBD06-00BD-4D23-955F-C9D933B81412Q34389831-3829D4B1-B267-476E-B142-7F1C438581BBQ34518795-FB88E0B3-F69E-4A38-A892-DF2A01AB75CCQ34551601-EF625F90-AA87-42F0-A0FB-E270C7631B28Q35450594-A1226F49-E8B1-40BD-88F9-F25268DFB26AQ35764595-08B3F867-42B5-48AF-8C84-1A9D115E7D8FQ36217451-277D276F-A20E-4FC4-9592-3B31EF0269F8Q36269761-AEF02147-F906-4F7A-91F2-319FD1C18739Q36351900-0C3AC297-DAD1-4C97-B8C9-D141812DD493Q36353359-ED94515B-D0BA-42FF-A404-1E987E92EB2DQ36670521-36180D6A-D78E-49C5-B219-0E32379B2028Q36812008-5B23DCBC-19CF-4179-B7EF-3C367C056ECAQ37027295-8524347A-52A7-4BDF-B98E-E02B59EE191DQ37558755-A42E72EF-5304-4954-88E5-F2A61469D970Q37657626-B2012D12-37AD-4103-BA8F-C58A14405C3CQ37806238-3B999B65-E9AF-49DD-B538-523BD7161226Q37817023-1E8B79A5-F163-4F5E-844A-2AC0DB6099BFQ38128321-190EAEE8-BBBE-4D43-AA68-F82B92802980Q38669149-CDEA7592-701D-4401-B372-75C51BD92829Q38785881-A8DCF131-AC98-4206-AAD1-3A0AF8A6BB5DQ39463162-A1FE15AD-74D9-4ED1-BC90-3201A2F888AEQ39546714-289DB282-6FC2-4012-8A90-7DA1CB35DFB5Q40491370-8A33080E-9D42-4D6F-B3AA-9D5A311EE18FQ40530719-ACD05107-DF67-4094-A474-ECD2B7D5E5FCQ40664707-058F1A5E-8415-414D-8C19-30F3DF7A0E15Q41514749-620B93F2-3FFD-4A85-B3C7-A92A217051BDQ41821669-99DAA9A6-B782-472D-8F8B-497B7EF763A9Q41837533-2251B951-4544-4C34-A98B-D642D37191F6Q41880321-D73AB3B3-6D5E-4707-9B3B-0291BE89D5DDQ42006587-E3DFA7DF-EFBA-4715-BF19-A88873188E84Q53262195-4E7E9398-4314-45C0-A78E-59C6FE5A25A7
P2860
Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.
description
1984 nî lūn-bûn
@nan
1984 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Detection and partial characte ...... activator in human platelets.
@ast
Detection and partial characte ...... activator in human platelets.
@en
Detection and partial characte ...... activator in human platelets.
@nl
type
label
Detection and partial characte ...... activator in human platelets.
@ast
Detection and partial characte ...... activator in human platelets.
@en
Detection and partial characte ...... activator in human platelets.
@nl
prefLabel
Detection and partial characte ...... activator in human platelets.
@ast
Detection and partial characte ...... activator in human platelets.
@en
Detection and partial characte ...... activator in human platelets.
@nl
P2093
P2860
P356
P1476
Detection and partial characte ...... activator in human platelets.
@en
P2093
D J Loskutoff
L A Erickson
M H Ginsberg
P2860
P304
P356
10.1172/JCI111559
P407
P577
1984-10-01T00:00:00Z